Market Closed -
Nasdaq
04:00:00 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
0.82
USD
|
-5.02%
|
|
+17.99%
|
-13.87%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,736
|
1,759
|
444.2
|
464.3
|
406.6
|
-
|
-
|
Enterprise Value (EV)
1 |
1,664
|
1,479
|
340.5
|
341.4
|
324.1
|
334.9
|
314.5
|
P/E ratio
|
-5.27
x
|
-2.62
x
|
-1.31
x
|
-2.15
x
|
-4.09
x
|
-4.53
x
|
-5.46
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.58
x
|
1.19
x
|
0.13
x
|
0.23
x
|
0.3
x
|
0.3
x
|
0.29
x
|
EV / Revenue
|
2.47
x
|
1
x
|
0.1
x
|
0.17
x
|
0.24
x
|
0.25
x
|
0.22
x
|
EV / EBITDA
|
-22,369,412
x
|
-3,132,881
x
|
-1,139,951
x
|
-7,645,277
x
|
-
|
-
|
12,502,358
x
|
EV / FCF
|
-
|
-5,224,509
x
|
-1,633,729
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.25
x
|
1.28
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
103,500
|
472,802
|
477,944
|
487,644
|
495,800
|
-
|
-
|
Reference price
2 |
16.77
|
3.720
|
0.9295
|
0.9521
|
0.8200
|
0.8200
|
0.8200
|
Announcement Date
|
3/1/21
|
2/23/22
|
2/28/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
672.9
|
1,472
|
3,477
|
2,034
|
1,338
|
1,349
|
1,413
|
EBITDA
|
-74.39
|
-472
|
-298.7
|
-44.66
|
-
|
-
|
25.15
|
EBIT
1 |
-92.71
|
-637
|
-370.9
|
-208.5
|
-121
|
-121.4
|
-134.1
|
Operating Margin
|
-13.78%
|
-43.27%
|
-10.67%
|
-10.25%
|
-9.04%
|
-9%
|
-9.49%
|
Earnings before Tax (EBT)
1 |
-91.58
|
-587.8
|
-338.8
|
-213.4
|
-121.3
|
-121.4
|
-134.1
|
Net income
1 |
-136.4
|
-587.8
|
-338.8
|
-213.4
|
-107
|
-95.41
|
-80.77
|
Net margin
|
-20.27%
|
-39.93%
|
-9.75%
|
-10.49%
|
-7.99%
|
-7.07%
|
-5.72%
|
EPS
2 |
-3.180
|
-1.420
|
-0.7115
|
-0.4425
|
-0.2004
|
-0.1811
|
-0.1501
|
Free Cash Flow
|
-
|
-283
|
-208.4
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-19.23%
|
-5.99%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/21
|
2/23/22
|
2/28/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
427.2
|
432
|
874.4
|
846.7
|
856.8
|
898.8
|
527.8
|
513.6
|
482.1
|
510.3
|
346.9
|
338.8
|
325.9
|
326.8
|
338.2
|
EBITDA
1 |
-102.3
|
-154.8
|
-71.76
|
-87.47
|
-58.31
|
-81.12
|
-30.46
|
10.02
|
-5.13
|
-19.09
|
6.82
|
2.439
|
2.311
|
-
|
14.79
|
EBIT
1 |
-149.3
|
-186.8
|
-87.3
|
-102.5
|
-73.92
|
-107.2
|
-72.61
|
-28.81
|
-41.47
|
-65.66
|
-22.7
|
-33.2
|
-32.18
|
-32.88
|
-23
|
Operating Margin
|
-34.94%
|
-43.23%
|
-9.98%
|
-12.11%
|
-8.63%
|
-11.92%
|
-13.76%
|
-5.61%
|
-8.6%
|
-12.87%
|
-6.54%
|
-9.8%
|
-9.87%
|
-10.06%
|
-6.8%
|
Earnings before Tax (EBT)
1 |
-34.53
|
-187.2
|
-75.31
|
-104.2
|
-75.31
|
-84.05
|
-72.61
|
-28.81
|
-41.47
|
-70.47
|
-23.17
|
-33.16
|
-32.16
|
-32.87
|
-23
|
Net income
1 |
-34.53
|
-187.2
|
-75.31
|
-104.2
|
-75.31
|
-84.05
|
-72.61
|
-28.81
|
-41.47
|
-70.47
|
-19.17
|
-28.13
|
-27.38
|
-28.3
|
-22.83
|
Net margin
|
-8.08%
|
-43.33%
|
-8.61%
|
-12.3%
|
-8.79%
|
-9.35%
|
-13.76%
|
-5.61%
|
-8.6%
|
-13.81%
|
-5.53%
|
-8.3%
|
-8.4%
|
-8.66%
|
-6.75%
|
EPS
2 |
-0.0800
|
-0.4400
|
-0.1600
|
-0.2188
|
-0.1577
|
-0.1759
|
-0.1516
|
-0.0601
|
-0.0863
|
-0.1463
|
-0.0390
|
-0.0528
|
-0.0516
|
-0.0557
|
-0.0446
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/8/21
|
2/23/22
|
5/9/22
|
8/8/22
|
11/7/22
|
2/28/23
|
5/9/23
|
8/8/23
|
11/6/23
|
3/12/24
|
5/7/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
71.5
|
280
|
104
|
123
|
82.5
|
71.7
|
92.1
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-283
|
-208
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-476%
|
-76.7%
|
-67.3%
|
-30.4%
|
-24.2%
|
-21.8%
|
ROA (Net income/ Total Assets)
|
-45.1%
|
-96.5%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
302.1
|
609
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
1.150
|
0.7300
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-2.760
|
-0.6800
|
-0.4300
|
-
|
-
|
-
|
-
|
Capex
|
0.69
|
0.72
|
4.47
|
-
|
-
|
-
|
-
|
Capex / Sales
|
0.1%
|
0.05%
|
0.13%
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/21
|
2/23/22
|
2/28/23
|
3/12/24
|
-
|
-
|
-
|
Last Close Price
0.82
USD Average target price
1.333
USD Spread / Average Target +62.60% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.87% | 407M | | -2.59% | 472B | | +14.34% | 125B | | +16.34% | 98.97B | | -26.70% | 40.44B | | -1.86% | 20.78B | | -25.95% | 2.65B | | -20.67% | 1.31B |
Other Managed Healthcare
|